Fig 3.

Cumulative risk of thrombosis in patients with lung cancer stratified by chemotherapy regimen. Risk of experiencing a thromboembolic event (TEE) during the first 180 days after the start of treatment for patients with lung cancer. The cohort is stratified by chemotherapy regimen: not platinum-based agents (red, solid line) or platinum-based agents (blue, dashed line). Confidence intervals are represented by the shaded region around each line. P value computed by log-rank. [Colour figure can be viewed at wileyonlinelibrary.com]